Abstract:Background Cardiac hypertrophy (CH) is a physiological response that compensates for blood pressure overload. Under pathological conditions, hypertrophy can progress to heart failure as a consequence of the disorganized growth of cardiomyocytes and cardiac tissue. USP10 (ubiquitin‐specific protease 10) is a member of the ubiquitin‐specific protease family of cysteine proteases, which are involved in viral infection, oxidative stress, lipid drop formation, and heat shock. However, the role of USP10 in CH remains largely unclear. Here, we investigated the roles of USP10 in CH. Methods and Results Cardiac‐specific USP10 knockout (USP10‐CKO) mice and USP10‐transgenic (USP10‐TG) mice were used to examined the role of USP10 in CH following aortic banding. The specific functions of USP10 were further examined in isolated cardiomyocytes. USP10 expression was increased in murine hypertrophic hearts following aortic banding and in isolated cardiomyocytes in response to hypertrophic agonist. Mice deficient in USP10 in the heart exhibited exaggerated cardiac hypertrophy and fibrosis following pressure overload stress, which resulted in worsening of cardiac contractile function. In contrast, cardiac overexpression of USP10 protected against pressure overload‐induced maladaptive CH. Mechanistically, we demonstrated that USP10 activation and interaction with Sirt6 in response to angiotensin II led to a marked increase in the ubiquitination of Sirt6 and resulted in Akt signaling downregulation and attenuation of cardiomyocyte hypertrophy. Accordingly, inactivation of USP10 reduced Sirt6 abundance and stability and diminished Sirt6‐induced downstream signaling in cardiomyocytes. Conclusions USP10 functions as a Sirt6 deubiquitinase that induces cardiac myocyte hypertrophy and triggers maladaptive CH. Nonstandard Abbreviations and Acronyms AB aortic banding CH cardiac hypertrophy LVEDd left ventricular end‐diastolic diameter mTOR mammalian target of rapamycin NRCMs neonatal rat cardiomyocytes Sirt6 sirtuin 6 TG transgenic USP10 ubiquitin‐specific protease 10 USP10‐CKO cardiac‐specific USP10 knockout Clinical Perspective What Is New? USP10 (ubiquitin‐specific protease 10) protects against pressure overload‐induced cardiac hypertrophy. USP10 physically binds to sirtuin 6 and sirtuin 6 mediates the effect of USP10 on the regulation of cardiac hypertrophy. What Are the Clinical Implications? This study expands the current knowledge of the role of the USP family in cardiovascular diseases and establishes a molecular link between USP10 and sirtuin 6 in the regulation of myocardial remodeling and the progression of cardiac hypertrophy. Cardiac hypertrophy (CH) is a significant risk factor for cardiovascular disease, including heart failure, sudden death, and arrhythmia, and remains a major public health problem. 1 , 2 It represents an adaptive response of the heart to various physiological or pathological stimuli, which is characterized by an abnormal thickening of the left ventricular wall and a decreased cavity size of the ventricular chamber. 3 Moreover, CH can be the result of genetic alterations or the outcome of increased cardiac workload and neurohumoral activation, the latter being identified as reactive CH. 4 Usually, an alternative gene expression program that is involved in CH results in altered cellular protein levels during myocyte growth and cardiac remodeling. CH not only upregulates prohypertrophic genes but also downregulates antihypertrophic genes. A large number of studies have shown that preventing the initial development of CH or the escalati -Abstract Truncated-

Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21

Deubiquitinase USP47 ameliorates cardiac hypertrophy through reducing protein O-GlcNAcylation

Cardiomyocyte-enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3-CARM1 Axis

USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes

Inhibition of TRPC1 Prevents Cardiac Hypertrophy Via NF-κB Signaling Pathway in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy

Ubiquitin specific protease 38 aggravates pathological cardiac remodeling by stabilizing phospho-TBK1

Angiotensin II-induced calcium overload affects mitochondrial functions in cardiac hypertrophy by targeting the USP2/MFN2 axis

USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart

USP20 deletion promotes eccentric cardiac remodeling in response to pressure overload and increases mortality

Deubiquitinase OTUD6a Drives Cardiac Inflammation and Hypertrophy by Deubiquitination of STING.

Deubiquitinase Ubiquitin-Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy.

USP38 exacerbates pressure overload-induced left ventricular electrical remodeling

Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction

Deubiquitinating enzyme USP30 negatively regulates mitophagy and accelerates myocardial cell senescence through antagonism of Parkin

OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes

Abstract 12936: A Critical Role of Deubiquitinase OTUB1 in Adaptive Cardiac Hypertrophy

The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy

USP14 modulates cell pyroptosis and ameliorates doxorubicin-induced cardiotoxicity by deubiquitinating and stabilizing SIRT3

The Ubiquitin Ligase HERC2 Promotes Ang II-induced Cardiac Hypertrophy Via Destabilization of MeCP2 to Enhance Lin28a Expression

METTL3-mediated m6A modification of OTUD1 aggravates press overload induced myocardial hypertrophy by deubiquitinating PGAM5